♦ Introduction
- Most commonly encountered benign intracranial mass
- Derive from arachnoid cap cells and can be highly vascular
- Embolization to improve surgical outcomes and reduce intraoperative blood loss
- Widespread use to all meningiomas is not advised given the additional risk of the procedure and the limited benefit in small superficial lesions.
♦ Preoperative
- All patients undergo preoperative testing, including electrolytes, blood urea nitrogen/creatinine and glomerular filtration rate; patients with borderline renal function should undergo intravenous (IV) bicarbonate administration with oral N-acetylcysteine.
- Careful examination of magnetic resonance imaging/computed tomography with contrast to determine possible target vessels of study
- Maintain IV hydration using isotonic fluids (normal saline or lactated Ringer’s solution) during and postprocedure.
- Administer steroids and antiepileptic agent prior to embolization in anticipation of the possible increased cytotoxic edema following embolization.
- A lucid understanding of the vascular anatomy is required to successfully and safely perform embolization of meningiomas.
Vascular Anatomy
- Convexity and falx meningiomas are usually supplied by the middle meningeal artery (MMA), anterior falcine branch of the anterior ethmoidal, or anterior or posterior cerebral artery branches.
- The MMA often supplies sphenoid wing meningiomas; petroclival tumors may also be supplied by the meningohypophyseal branch of the ICA or from the neuromeningeal trunk of the ascending pharyngeal artery. Olfactory groove tumors typically are supplied from the anterior or posterior ethmoidal arteries.
- Posterior fossa meningiomas often receive supply from the occipital artery via transosseous perforators and from the posterior meningeal artery. Tentorial meningiomas can be supplied by the meningohypophyseal trunk via the artery of Bernasconi and Casinari.
- Cerebellopontine angle tumors can be supplied by the MMA or the ascending pharyngeal, occipital, or subarcuate arteries. Foramen magnum meningiomas can be supplied from occipital or ascending pharyngeal artery branches.
- Parasellar meningiomas may have multiple feeders from the ICA as well as the MMA, accessory meningeal, or internal maxillary arteries.
Special Equipment
- 4 French (F) diagnostic catheter (UCSF-2 or Berenstein-2; Cordis, Bridgewater, NJ) and 0.035 in hydrophilic guide wire (Terumo glidewire, Terumo, Somerset, NJ)
- 5F guide catheter (Envoy MPD or MPC, Cordis) for intervention
- Microcatheter system (SL-10 or Excel 14, Boston Scientific); if using Onyx (ethylene-vinyl alcohol copolymer [EVOH]/dimethyl sulfoxide [DMSO]) ensure DMSO-compatibility of microcatheter
- Shapeable and ultranavigable 0.014 microwire (Synchro-2, Boston Scientific) for intracranial navigation
- For tumor embolization, the ideal embolic material would propagate to the tumor capillaries to maximize tissue devascularization and necrosis. Smaller particles can travel through vasa nervorum or occlude adjacent normal tissue; larger particles are more likely to lodge proximally and fail to reach tumor capillaries.
- Three major classes of embolic materials for meningioma devascularization:
- Particulate Embolic Agent
- Polyvinyl alcohol particles (irregular-shaped) or trisacryl gel microspheres (Embosphere; more uniform spheres) come in size ranges spanning 50 to 500 mcm. Do not use size < 150 mcm if significant risk of any reflux. Smaller 10-size microcatheters will enable easier distal navigation but cannot accommodate larger particles and are more prone to sludging, necessitating use of a more dilute particle solution.
- Liquid Embolic Agent
- N-butyl cyanoacrylate (NBCA) results in rapid polymerization when in contact with sodium, which can be slowed by admixing glacial acetic acid. NBCA is more difficult to control compared with EVOH, which polymerizes by diffusion of DMSO solvent. Onyx is available in two densities and enables better penetration. Caution: Onyx also can combust when it contacts monopolar cautery.
- Occlusive Coils
- Coils are used mainly following particulate embolization to further promote thrombosis and decrease risk of recanalization by flow reduction/interruption. Ideally, thrombogenic fibered coils should be used, otherwise hydrogel-coated (HydroCoil, MicroVention, Tustin, CA) or soft coils packed to a high density are also suitable.
- Particulate Embolic Agent
Anesthesia Issues
- Most cases can be performed under monitored anesthesia, unless patient is noncooperative.
- Consider general anesthesia if meningioma is near critical vascular anastomoses where optimal angiographic visualization is essential. Obtain temporary apnea during angiographic run or critical roadmap.
- Microinjection using 1 mL of 1% lidocaine prior to use of NBCA or EVOH/DMSO to avoid excruciating dural pain.
Monitoring
- Provocative test microinjection using 1 mL of 1% lidocaine when near critical cranial nerve vascular supply
- Always test injection with contrast prior to injection of embolic agent to evaluate rate of flow and assess for changes mid-embolization.
- If patient is awake, perform appropriate focused neurologic testing before and after embolization of each pedicle to rule out new embolization-induced deficit.
♦ Intraoperative
- Patient supine on biplane angiography suite table and an initial 4F sheath is inserted into the femoral artery, obtain baseline activated clotting time (ACT)
- A complete diagnostic angiogram is performed to include external and internal (if indicated by location) carotid arteries and bilaterally (in case of midline lesions) to include the vertebral arteries (in case of posterior lesions).
- Careful analysis of likely dangerous vascular anastomoses based on tumor location such as:
- Internal maxillary to ophthalmic artery, vidian artery, or inferolateral trunk of the internal carotid artery
- Ascending pharyngeal artery to vidian artery or inferolateral trunk
- Occipital artery to vertebral artery
- After identifying target feeder pedicles and formulating a plan for embolization (if appropriate), upsize vascular sheath to 5F.
- Administer intravenous heparin to one and a half times baseline ACT.
- Place guide catheter in parent vessel as distally as possible for safety but without interrupting or slowing distal flow to the feeder pedicle.
- Navigate microcatheter over microwire with gentle technique to avoid iatrogenic vasospasm, which would hamper or prevent actual embolization of the tumor.
- Careful analysis of likely dangerous vascular anastomoses based on tumor location such as:
For Particulate Embolization
- Maintenance of flow around microcatheter is critical to carry particles to distal tumor bed (do not wedge microcatheter); always check for mechanical vasospasm.
- Do not use particles smaller than 100 mcm in critical territories or near anastomoses.
- Use a dilute particle solution and use pulsatile injection to avoid sludging in microcatheter, which can lead to occlusion.
- In case of increased flow resistance, avoid high-pressure injection, which could lead to proximal rupture of particle-laden microcatheter (withdraw and discard latter).
- Always consider the remaining particles within the microcatheter dead-space when nearing stasis point.
- After embolization to complete stasis, consider proximal coiling of pedicle to decrease likelihood of recanalization until craniotomy is performed.
- Do not use particles smaller than 100 mcm in critical territories or near anastomoses.
For Liquid Embolization
- Wedge microcatheter as far as possible to ensure distal injection with minimal reflux. With EVOH, use varying Onyx densities to form initial plug then use lower density to permeate tumor distally (34 then 18).
- Do not attempt to reuse or recatheterize with same microcatheter.
- Avoid casting microcatheter tip too extensively with EVOH, which could increase resistance to withdrawal at end of embolization and lead to iatrogenic proximal parent vessel vasospasm, hindering subsequent pedicle embolization.
- Watch time carefully with NBCA to avoid gluing the microcatheter tip into the pedicle.
- Do not attempt to reuse or recatheterize with same microcatheter.
- It is critical in all cases to closely follow the alteration in hemodynamics and tumor perfusion and appearance of previously nonvisualized anastomoses during the course of the embolization procedure.
- Perform frequent updates to the negative roadmap to visualize where the embolic material is traveling.
- Perform frequent interval diagnostic angiographic runs mid-embolization to recognize any unexpected findings that may alter course of procedure.
- Proximally deployed coils alone do not provide adequate preoperative embolization because they fail to penetrate the tumor capillary bed.
- Always flush back and back-bleed guide catheter after withdrawal of micro-catheter or replace guide completely if in doubt to avoid subsequent embolic shower to normal cerebral vessels.
Closure
- At the end of the procedure, remove guide catheter, perform postembolization diagnostic angiogram, and evaluate need for additional treatment; rule out normal vessel branch occlusion.
- Obtain postembolization ACT and consider partial heparin reversal with slow protamine infusion if ACT is greater than one and a half times baseline in absence of ischemic deficit.
- Image sheath insertion site and consider using a collagen-based closure device (Angio-Seal), umbrella-type assistive device (Boomerang, Cardiva Medical, Inc., Sunnyvale, CA) or simple manual compression.
♦ Postoperative
< div class='tao-gold-member'>
Only gold members can continue reading. Log In or Register a > to continue
